-
Biologic Therapy
5000033
global
1
0.5
9
0.5
0.5
Commentary
0
1
Hematology-Oncology2023-05-24 20:00:00
Do you know what toxicities to watch for in patients being treated with bispecific antibodies?
0.5ABIM MOC
0.5CME/CE
30MIN
Save
-
Prostate Cancer
3003438
global
1
0.5
9
0.5
0.5
Roundtable
0
1
Radiology2023-05-24 20:00:00
How are you managing your prostate cancer patients on active surveillance?
0.5ABIM MOC
0.5CME/CE
30MIN
Save
-
Multiple Myeloma
1166
global
3
0.5
0.5
Roundtable
0
1
Hematology-Oncology2023-05-24 20:00:00
Elevate your management of multiple myeloma from the pharmacy to the bedside.
0.5ABIM MOC
0.5CME/CE
30MIN
Save
-
Multiple Myeloma
1166
global
1
0.5
9
0.5
0.5
Roundtable
0
1
Hematology-Oncology2023-05-24 20:00:00
Learn the what, when, and how of multimodal disease assessment in the hematopathology lab for your patients with myeloma.
0.5ABIM MOC
0.5CME/CE
30MIN
Save
-
Bladder Cancer
821
global
1
1.25
9
1.25
1.25
Roundtable
0
1
Urology2023-05-22 20:00:00
Did you know that immunotherapy-based regimens are being used to treat patients with high-risk non-muscle invasive bladder cancer (HR-NMIBC) leading to improved outcomes?
1.25ABIM MOC
1.25CME/CE
75MIN
Save
-
Thrombocytopenia
1154
global
3
1.25
1.25
Roundtable
0
1
Hematology-Oncology2023-05-18 20:00:00
Learn more on the integral role pharmacists play in inpatient, day of discharge, and outpatient transitions for patients with acquired thrombotic thrombocytopenic purpura (aTTP).
1.25ABIM MOC
1.25CME/CE
75MIN
Save
-
Breast Cancer
840
global
1
0.25
9
0.25
2
0.25
8
0.25
0.25
Clinical Brief
0
1
Hematology-Oncology2023-05-25 20:00:00
Did you know that a new study shows bariatric surgery is associated with lower overall risk for breast cancer?
0.25ABIM MOC
0.25CME/CE
15MIN
Save
-
Biologic Therapy
5000033
global
1
0.5
9
0.5
0.5
Commentary
0
1
Hematology-Oncology2023-05-24 20:00:00
Do you know what toxicities to watch for in patients being treated with bispecific antibodies?
0.5ABIM MOC
0.5CME/CE
30MIN
Save
-
Prostate Cancer
3003438
global
1
0.5
9
0.5
0.5
Roundtable
0
1
Radiology2023-05-24 20:00:00
How are you managing your prostate cancer patients on active surveillance?
0.5ABIM MOC
0.5CME/CE
30MIN
Save
-
Multiple Myeloma
1166
global
3
0.5
0.5
Roundtable
0
1
Hematology-Oncology2023-05-24 20:00:00
Elevate your management of multiple myeloma from the pharmacy to the bedside.
0.5ABIM MOC
0.5CME/CE
30MIN
Save
-
Multiple Myeloma
1166
global
1
0.5
9
0.5
0.5
Roundtable
0
1
Hematology-Oncology2023-05-24 20:00:00
Learn the what, when, and how of multimodal disease assessment in the hematopathology lab for your patients with myeloma.
0.5ABIM MOC
0.5CME/CE
30MIN
Save
-
Bladder Cancer
821
global
1
1.25
9
1.25
1.25
Roundtable
0
1
Urology2023-05-22 20:00:00
Did you know that immunotherapy-based regimens are being used to treat patients with high-risk non-muscle invasive bladder cancer (HR-NMIBC) leading to improved outcomes?
1.25ABIM MOC
1.25CME/CE
75MIN
Save
-
Thrombocytopenia
1154
global
3
1.25
1.25
Roundtable
0
1
Hematology-Oncology2023-05-18 20:00:00
Learn more on the integral role pharmacists play in inpatient, day of discharge, and outpatient transitions for patients with acquired thrombotic thrombocytopenic purpura (aTTP).
1.25ABIM MOC
1.25CME/CE
75MIN
Save
-
Melanoma
65
global
2
1.25
1.25
Roundtable
0
1
Hematology-Oncology2023-05-18 20:00:00
Do you know the latest news in combination therapy for melanoma?
1.25ABIM MOC
1.25CME/CE
75MIN
Save
-
Multiple Myeloma
1166
global
2
1.25
1.25
Roundtable
0
1
Nursing2023-05-17 20:00:00
Explore the crucial roles nurses play in the complex care of patients with multiple myeloma (MM), including clinical application of the latest therapies.
1.25ABIM MOC
1.25CME/CE
75MIN
Save
-
Skin Cancer
56
global
2
0.75
0.75
Roundtable
0
1
Hematology-Oncology2023-05-17 20:00:00
Do you know how to manage patients with nonmelanoma skin cancer?
0.75ABIM MOC
0.75CME/CE
45MIN
Save
-
Thrombocytopenia
1154
global
1
1.0
9
1.0
1.0
Journal Article
0
1
Hematology-Oncology2023-05-17 20:00:00
Targeting clonally expanded CD8+ T cells could be a novel therapeutic approach for refractory immune thrombocytopenia.
1.0ABIM MOC
1.0CME/CE
60MIN
Save
-
Multiple Myeloma
1166
global
1
1.0
9
1.0
2
1.0
3
1.0
1.0
Clinical Review
0
1
Hematology-Oncology2023-05-16 20:00:00
B-cell maturation antigen (BCMA)-targeted approaches: get the latest updates for your patients with relapsed/refractory multiple myeloma (MM).
1.0ABIM MOC
1.0CME/CE
60MIN
Save
-
Hodgkin Lymphoma
1545
global
1
0.5
9
0.5
2
0.5
3
0.5
8
0.5
0.5
Clinical Review
0
1
Hematology-Oncology2023-05-15 20:00:00
How well do you take into account the long-term complications of treatment when planning care for your patients with Hodgkin lymphoma?
0.5ABIM MOC
0.5CME/CE
30MIN
Save
-
Stem Cell Research and Therapy
3032536
global
1
1.0
9
1.0
1.0
Roundtable
0
1
Radiology2023-05-11 20:00:00
How are oncologists and radiologists collaborating to diagnose and treat veno-occlusive disease and sinusoidal obstruction syndrome (VOD/SOS) before the patient is critically ill?
1.0ABIM MOC
1.0CME/CE
60MIN
Save
-
0
global
1
0.25
9
0.25
2
0.25
3
0.25
8
0.25
0.25
Clinical Brief
0
1
Diabetes & Endocrinology2023-05-11 20:00:00
Sugar consumption has been linked to multiple negative health outcomes in an umbrella review of meta-analyses.
0.25ABIM MOC
0.25CME/CE
15MIN
Save
-
Mesothelioma
3029373
global
1
0.25
9
0.25
2
0.25
3
0.25
0.25
Expert Column
0
1
Hematology-Oncology2023-05-07 20:00:00
Can combination therapies improve outcomes for patients with mesothelioma?
0.25ABIM MOC
0.25CME/CE
15MIN
Save
-
Atrial Fibrillation
390
global
1
0.25
9
0.25
2
0.25
3
0.25
8
0.25
0.25
Clinical Brief
0
1
Hematology-Oncology2023-05-04 20:00:00
A new study analyzes the rate of atrial fibrillation with anticancer drugs.
0.25ABIM MOC
0.25CME/CE
15MIN
Save
-
Non-Small Cell Lung Cancer
3004986
us
1
0.5
9
0.5
0.5
Roundtable
0
1
General Surgery2023-05-03 20:00:00
The complexity of treatment has increased dramatically; how effectively are you communicating with your patients?
0.5ABIM MOC
0.5CME/CE
30MIN
Save
